Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 May 2006

Urinary activities of cathepsin B, N-acetyl-ss-D-glucosaminidase, and albuminuriain patients with type 2 diabetes mellitus.

Agnieszka Piwowar, Maria Knapik-Kordecka, Izabela Fus, Maria Warwas

Med Sci Monit 2006; 12(5): CR210-214 :: ID: 450290

Abstract

Background: The proximal kidney tubule contains a large number of lysosomesinvolved in the breakdown of intracellular as well as reabsorbed proteins. When tubular protein reabsorptionis overburdened or when there is tubular cell damage, higher urinary excretion of lysosomal enzymes,e.g. cathepsins and N-acetyl-beta-D-glucosaminidase (NAG), can be found. We compared urinary cathepsinB (CB) activity with NAG in diabetic patients. Material/Methods: Using fluorogenic substrates, urinaryand plasma CB and NAG activities in 130 type 2 diabetic patients with varying stages of albuminuria and42 control subjects were determined. Early morning urine samples were used. Results: In the patients,only higher values of plasma NAG were found. In urine, CB and NAG activities increased progressivelyfrom normoalbuminuria, through microalbuminuria to macroalbuminuria group. The normoalbuminuria grouphad both enzyme activities higher than healthy controls. Urine CB activity in the patients also increasedgradually to tertiles of urinary NAG. Only urinary CB activity was significantly associated with glycemicstate. The correlation was stronger in the patients with poor glycemic control. The plasma/urine ratiosfor both CB and NAG decreased in the patients compared with controls. Conclusions: Determination of urinaryCB activity might be useful as a non-invasive surrogate marker of incipient nephropathy.

Keywords: Acetylglucosaminidase - urine, Aged, 80 and over, Albuminuria - urine, Biological Markers - urine, Case-Control Studies, Cathepsin B - urine, Diabetes Mellitus, Type 2 - urine, Diabetic Nephropathies - urine

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

08 Feb 2024 : Clinical Research  

Serum Selenium Concentration as a Potential Diagnostic Marker for Early-Stage Colorectal Cancer: A Comparat...

Med Sci Monit In Press; DOI: 10.12659/MSM.942882  

09 Feb 2024 : Clinical Research  

Factors Influencing the Occurrence of Intraoperative Hypothermia in Patients Undergoing General Anesthesia ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943463  

13 Feb 2024 : Clinical Research  

A Retrospective Study to Compare the Glasgow Coma Score, Pediatric Trauma Score, and Injury Severity Score ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943501  

16 Feb 2024 : Clinical Research  

Etiology, Clinical Presentation, and Outcomes of Bacterial Meningitis in Adult Patients: A Retrospective St...

Med Sci Monit In Press; DOI: 10.12659/MSM.942904  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750